Influence of atrial fibrillation on plasma von Willebrand factor, soluble E-selectin, and N-terminal pro B-type natriuretic peptide levels in systolic heart failure

被引:30
作者
Freestone, Bethan [1 ]
Gustasson, Finn
Chong, Aun Yeong [1 ]
Corell, Pernille [2 ]
Kistorp, Caroline [3 ]
Hildebrandt, Per [4 ]
Lip, Gregory Y. H. [1 ]
机构
[1] City Hosp, Univ Dept Med, Haemostasis Thrombosis & Vasc Biol Unit, Birmingham B18 7HQ, W Midlands, England
[2] Frederiksberg Univ Hosp, Dept Cariol & Endocrinol E, Frederiksberg, Denmark
[3] Herlev Univ Hosp, Dept Endocrinol, DK-2730 Herlev, Denmark
[4] Roskilde Univ Hosp, Dept Med, Roskilde, Denmark
关键词
atrial fibrillation; heart failure; N-terminal pro B-type natriuretic peptide; von Willebrand factor;
D O I
10.1378/chest.07-2557
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
Background: Endothelial dysfunction is present in patients with heart failure (HF) due to left ventricular systolic dysfunction, as well as in patients with atrial fibrillation (AF) who have normal cardiac function. it is unknown whether AF influences the degree of endothelial dysfunction in patients with systolic HF. Methods: We measured levels of plasma von Willebrand factor (vWF) and E-selectin (as indexes of endothelial damage/dysfunction and endothelial activation, respectively; both enzyme-linked immunosorbent assay) in patients with AF and HF (AF-HF), who were compared to patients with sinus rhythm and HF (SR-HF), as well as in age-matched, healthy, control subjects. We also assessed the relationship of vWF and E-selectin to plasma N-terminal pro B-type natriuretic peptide (NTpro-BNP), a marker for HF severity and prognosis. Results: One hundred ninety patients (73% men; mean age, 69.0 +/- 10.1 years [+/- SD]) with systolic HF were studied, who were compared to 117 healthy control subjects: 52 subjects (27%) were in AF, while 138 subjects (73%) were in sinus rhythm. AF-HF patients were older than SR-HF patients (p = 0.046), but left ventricular ejection fraction and New York Heart Association class were similar. There were significant differences in NT-proBNP (p < 0.0001) and plasma vWF (p = 0.003) between patients and control subjects. On Tukey post hoe analysis, AF-HF patients had significantly increased NT-proBNP (p < 0.001) and vWF (p = 0.0183) but not E-selectin (p = 0.071) levels when compared to SR-HF patients. On multivariate analysis, the presence of AF was related to plasma vWF levels (p = 0.018). Plasma vWF was also significantly correlated with NT-proBNP levels (Spearman r = 0.139; p = 0.0117). Conclusions: There is evidence of greater endothelial damage/dysfunction in AF-HF patients when compared to SR-HF patients. The clinical significance of this is unclear but may have prognostic value.
引用
收藏
页码:1203 / 1208
页数:6
相关论文
共 50 条
  • [41] Prognostic value of carbohydrate antigen 125 combined with N-terminal pro B-type natriuretic peptide in patients with acute heart failure
    Chen, Xi
    Wu, Meifang
    Xu, Kaizu
    Huang, Meinv
    Zhuo, Xiuping
    [J]. ACTA CARDIOLOGICA, 2021, 76 (01) : 87 - 92
  • [42] Plasma B-type natriuretic peptide levels in ambulatory patients with established chronic symptomatic systolic heart failure
    Tang, WHW
    Girod, JP
    Lee, MJ
    Starling, RC
    Young, JB
    Van Lente, F
    Francis, GS
    [J]. CIRCULATION, 2003, 108 (24) : 2964 - 2966
  • [43] Brain natriuretic peptide and N-terminal pro b-type natriuretic peptide in kidney transplantation: More than just cardiac markers
    Afsar, Baris
    Afsar, Rengin Elsurer
    Caliskan, Yasar
    Lentine, Krista L.
    [J]. TRANSPLANTATION REVIEWS, 2024, 38 (04)
  • [44] Mid-regional pro-adrenomedullin outperforms N-terminal pro-B-type natriuretic peptide for the diagnosis of acute heart failure in the presence of atrial fibrillation
    Sen Kuan, Win
    Ibrahim, Irwani
    Chan, Siew Pang
    Li, Zisheng
    Liew, Oi Wah
    Frampton, Chris
    Troughton, Richard
    Pemberton, Chris J.
    Chong, Jenny Pek Ching
    Tan, Li Ling
    Lin, Weiqin
    Ooi, Shirley Beng Suat
    Richards, A. Mark
    [J]. EUROPEAN JOURNAL OF HEART FAILURE, 2020, 22 (04) : 692 - 700
  • [45] Association between plasma brain natriuretic peptide/N-terminal pro-brain natriuretic peptide levels and atrial fibrillation: evidence from a meta-analysis
    Liu Yaowu
    Xiao Yunyun
    Chen Xinguang
    Zhang Fengxiang
    [J]. CHINESE MEDICAL JOURNAL, 2014, 127 (15) : 2824 - 2828
  • [46] Stepwise mass screening for atrial fibrillation using N-terminal B-type natriuretic peptide: the STROKESTOP II study
    Gudmundsdottir, Katrin Kemp
    Fredriksson, Tove
    Svennberg, Emma
    Al-Khalili, Faris
    Friberg, Leif
    Frykman, Viveka
    Hijazi, Ziad
    Rosenqvist, Marten
    Engdahl, Johan
    [J]. EUROPACE, 2020, 22 (01): : 24 - 32
  • [47] Assessment of B-type natriuretic peptide (BNP) and N-terminal (NT)-proBNP in hypertensive patients with heart failure
    Degli Esposti, D
    Veronesi, M
    Cosentino, E
    Dormi, A
    Bacchelli, S
    Maione, D
    Prandin, MG
    Borghi, C
    Ambrosioni, E
    [J]. AMERICAN JOURNAL OF HYPERTENSION, 2004, 17 (05) : 81A - 82A
  • [48] The diagnostic value of N-terminal B-type natriuretic peptide in diastolic heart failure: comparison with echocardiographic findings
    Tugcu, Aylin
    Yildirimturk, Ozlem
    Aytekin, Saide
    [J]. TURK KARDIYOLOJI DERNEGI ARSIVI-ARCHIVES OF THE TURKISH SOCIETY OF CARDIOLOGY, 2009, 37 (02): : 112 - 121
  • [49] The Molar Ratio of N-terminal pro-B-type Natriuretic Peptide/B-type Natriuretic Peptide for Heart Failure-related Events in Stable Outpatients with Cardiovascular Risk Factors
    Suzuki, Satoru
    Sugiyama, Seigo
    [J]. INTERNAL MEDICINE, 2018, 57 (18) : 2621 - 2630
  • [50] Atrial fibrillation and amino-terminal pro-brain natriuretic peptide as independent predictors of prognosis in systolic heart failure
    Dini, Frank Lloyd
    Gabutti, Alessandra
    Passino, Claudio
    Fontanive, Paolo
    Emdin, Michele
    De Tommasi, Salvatore Mario
    [J]. INTERNATIONAL JOURNAL OF CARDIOLOGY, 2010, 140 (03) : 344 - 350